Researcher Profile Statistics: Lim Chwee Ming
Geo Map
Region
#
AS - Asia, other
12
AF - Africa
2
NA - North America
1
Unknown
16
Total
31
Country
#
SG - Singapore
9
MY - Malaysia
2
JP - Japan
1
NA - Namibia
1
NG - Nigeria
1
US - United States of America
1
Unknown
16
Total
31
City
#
Singapore
4
Jurong West New Town
2
Los Angeles
1
Port Harcourt
1
Puchong Batu Dua Belas
1
Sapporo
1
Seri Iskandar
1
Windhoek
1
Unknown
19
Total
31
Bitstream
Downloads
ID: 1390624 - Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma..pdf - ITEM:( 10635/175619)
13
Total: {0}
13
Most bitstream per type viewed
#
ID: other -
0
ID: journal -
29
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
1
ID: dataset -
0
ID: selected -
0
Total
30
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2020
0 0
0 0 0 0
0 0 2 1
0 0
3
2022
0 0
1 0 0 0
1 0 6 1
4 0
13
2023
1 2
0 1 5 3
0 1 0 0
2 0
15
Ever
31
Geo Map
Region | # |
---|---|
AS - Asia, other | 12 |
AF - Africa | 2 |
NA - North America | 1 |
Unknown | 16 |
Total | 31 |
Country | # |
---|---|
SG - Singapore | 9 |
MY - Malaysia | 2 |
JP - Japan | 1 |
NA - Namibia | 1 |
NG - Nigeria | 1 |
US - United States of America | 1 |
Unknown | 16 |
Total | 31 |
City | # |
---|---|
Singapore | 4 |
Jurong West New Town | 2 |
Los Angeles | 1 |
Port Harcourt | 1 |
Puchong Batu Dua Belas | 1 |
Sapporo | 1 |
Seri Iskandar | 1 |
Windhoek | 1 |
Unknown | 19 |
Total | 31 |
Bitstream | Downloads |
---|---|
ID: 1390624 - Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma..pdf - ITEM:( 10635/175619) | 13 |
Total: {0} | 13 |
Most bitstream per type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 29 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: allItems - | 0 |
ID: book - | 1 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 30 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 3 |
2022 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 6 | 1 | 4 | 0 | 13 |
2023 | 1 | 2 | 0 | 1 | 5 | 3 | 0 | 1 | 0 | 0 | 2 | 0 | 15 |
Ever | 31 |